Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B‐CLL patients: impact on clonal B‐cell apoptosis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  British Journal of Haematology

• Publication date

  2001-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2141.2001.02605.xPMID 11260081
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chlorambucil resistance in B‐cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl‐2‐expressing subclones

  1999cited by this paper
• IL4 production and increased CD30 expression by a unique CD8+ T‐cell subset in B‐cell chronic lymphocytic leukaemia

  1999cited by this paper
• Regulation of B-CLL apoptosis through membrane receptors and Bcl-2 family proteins.

  1998cited by this paper
• The cellular biology of B-cell chronic lymphocytic leukemia.

  1998cited by this paper
• Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.

  1998cited by this paper
• Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance.

  1998cited by this paper
• Cytoplasmic interleukin-4 (IL-4) and surface IL-4 receptor expression in patients with B-cell lymphocytic leukemia.

  1998cited by this paper
• Impairments in immune cell function in B cell chronic lymphocytic leukemia.

  1998cited by this paper
• Molecular biology of chronic lymphocytic leukemia: implications for therapy.

  1998cited by this paper
• Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.

  1998cited by this paper
• Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic leukemia patients.

  1997cited by this paper
• Chronic Lymphocytic Leukemia B Cells Are Resistant to the Apoptotic Effects of Transforming Growth Factor-β

  1997cited by this paper
• Analysis of blood T‐cell cytokine expression in B‐chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL‐4 in resting and activated CD8 T cells

  1997cited by this paper
• Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance.

  1997cited by this paper
• Production of cytokines by human B cells in health and disease.

  1997cited by this paper
• Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.

  1997cited by this paper
• Interleukin‐4 prevents spontaneous in‐vitro apoptosis in chronic lymphatic leukaemia but sensitizes B‐CLL cells to melphalan cytotoxicity

  1997cited by this paper
• Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia.

  1996influential reference
• Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.

  1996cited by this paper
• Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells.

  1996cited by this paper
• Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.

  1996cited by this paper
• Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.

  1996cited by this paper
• IL-13 expression at the sites of allergen challenge in patients with asthma.

  1995cited by this paper
• Effect of anti-APO1 on spontaneous apoptosis of B cells in chronic lymphocytic leukaemia: the role of bcl-2 and interleukin 4.

  1995cited by this paper
• Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

  1995cited by this paper
• The functional role of CD8+ T helper type 2 cells

  1995cited by this paper
• Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo

  1995cited by this paper
• Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection

  1994cited by this paper
• Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells

  1994cited by this paper
• Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc.

  1994cited by this paper
• Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4.

  1994cited by this paper
• Interferon‐alpha up‐regulates bcl‐2 expression and protects B‐CLL cells from apoptosis in vitro and in vivo

  1994cited by this paper
• Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes

  1993cited by this paper
• Normal and aberrant expression of cytokines in neoplastic cells from chronic lymphocytic leukemias.

  1993cited by this paper
• Interleukin‐4 inhibits apoptotic cell death and loss of the bcl‐2 protein in B‐chronic lymphocytic leukaemia cells in vitro

  1993influential reference
• Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia

  1993cited by this paper
• Preparation of CD8bright and CD8dim lymphocyte populations using two positive selection methods in tandem.

  1993cited by this paper
• Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression

  1992cited by this paper
• Evidence for functional subsets of CD4+ and CD8+ T cells in human disease: lymphokine patterns in leprosy.

  1992cited by this paper
• The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice

  1992cited by this paper
• Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

  1991cited by this paper
• Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.

  1991cited by this paper
• Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations.

  1991cited by this paper
• Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro.

  1990cited by this paper
• Spontaneous programmed death (apoptosis) of B‐chronic lymphocytic leukaemia cells following their culture in vitro

  1989cited by this paper
• Pharmacokinetic study of fludarabine phosphate (NSC 312887)

  1986cited by this paper

• The role of CD180 in hematological malignancies and inflammatory disorders

  2023cites this paper
• Resolution of eosinophilia and elevated immunoglobulin E with ibrutinib for chronic lymphocytic leukemia.

  2018cites this paper
• The role of telomere dysfunction in modulating disease progression and response to treatment in chronic lymphocytic leukaemia.

  2018cites this paper
• Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box.

  2016cites this paper
• High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells.

  2016cites this paper
• SUPPRESSION OF ANTI-TUMOR IMMUNITY IN CHRONIC LYMPHOCYTIC LEUKEMIA VIA INTERLEUKIN-10 PRODUCTION

  2016cites this paper
• Investigation into the efficacy of the anti-CD20 monoclonal antibody ofatumumab in chronic lymphocytic leukaemia

  2015cites this paper
• The expression of toll-like receptors in B-chronic lymphocytic leukaemia

  2015cites this paper
• The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia.

  2015cites this paper
• [Not Available].

  2014cites this paper
• Involvement of memory T-cells in the pathophysiology of chronic lymphocytic leukemia

  2014cites this paper
• Acute in Vitro effects of ABS (Ankaferd Hemostat) on the Lymphoid Neoplastic Cells (B-CLL and RAJI Tumor Cell Lines)

  2014cites this paper
• Characterising CD31/CD38 signalling in primary chronic lymphocytic leukaemia cells

  2013influential citation
• Rai stage-related changes within T/NK cell populati ons from B-CLL patients Modific ări ale popula ţiilor celulare T/NK la pacien ţi cu LLC-B în diferite stadii Rai

  2013cites this paper
• Rai stage-related changes within T/NK cell populations from B-CLL patients

  2013cites this paper
• patients with B-chronic lymphocytic leukemia Expression levels of CD38 in T-cells predict for course of disease in male

  2013cites this paper
• impairs self-renewal and partially restores myelopoiesis in leukemic CD34+ stem/progenitor cells α Re-introduction of C/EBP

  2013cites this paper
• Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP‐70 B‐chronic lymphocytic patients

  2013cites this paper
• Chronic Lymphocytic Leukemia: A Review for Primary Care Practitioners

  2012cites this paper
• Immune Reconstitution in Chronic Lymphocytic Leukemia

  2012cites this paper
• The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells

  2012cites this paper
• Immune dysfunction in chronic lymphocytic leukemia: the role for immunotherapy.

  2012cites this paper
• the microenvironment lymphocytic leukemia cells: potential for reversal of cytoprotection by cytotoxic agents induced by interleukin-4 treatment of chronic The JAK3-selective inhibitor PF-956980 reverses the resistance to

  2011cites this paper
• Modern strategies for hairy cell leukemia.

  2011cites this paper
• Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells

  2011cites this paper
• T-cell function in chronic lymphocytic leukaemia.

  2010cites this paper
• Chronic lymphocytic leukemia.

  2010cites this paper
• The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment.

  2010cites this paper
• Immunological and molecular studies for the development of vaccine therapy for chronic lymphocytic leukemia

  2010cites this paper
• P38 mitogen activated protein kinase expression and regulation by interleukin-4 in human B cell non-Hodgkin lymphomas

  2009cites this paper
• P 38 mitogen activated protein kinase expression and regulation by interleukin-4 in human B cell non-Hodgkin lymphomas

  2009cites this paper
• Transport of nucleoside analogs across the plasma membrane: a clue to understanding drug-induced cytotoxicity.

  2009cites this paper
• Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?

  2008cites this paper
• CLL-Specific Complications: Autoimmunity and Richter’s Transformation

  2008cites this paper
• Expression et fonctionnalité des Toll-Like récepteurs par les cellules de leucémie lymphoïde chronique B

  2008cites this paper
• Cellular immune therapy for chronic lymphocytic leukemia.

  2007cites this paper
• The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth?

  2007cites this paper
• 17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis

  2007cites this paper
• University of Groningen Reintroduction of C/EBP alpha in leukemic CD34(+) stem/progenitor cells impairs self- renewal and partially restores myelopoiesis Schepers,

  2007cites this paper
• Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.

  2006cites this paper
• Tumor-derived interleukin-4 reduces tumor clearance and deviates the cytokine and granzyme profile of tumor-induced CD8+ T cells.

  2006cites this paper
• Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation.

  2006cites this paper
• Low expression of costimulatory molecules and mRNA for cytokines are important mechanisms of immunosuppression in acute lymphoblastic leukemia in children?

  2006cites this paper
• Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokines.

  2006cites this paper
• Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels.

  2006cites this paper
• T-cell abnormalities in patients with chronic lymphocytic leukemia

  2006cites this paper
• Emerging drugs for chronic lymphocytic leukaemia

  2006cites this paper
• Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.

  2006cites this paper
• A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells.

  2005cites this paper
• Chronic lymphocytic leukemia: a review of some new aspects of the biology, factors influencing prognosis and therapeutic options.

  2005cites this paper
• Enhanced Expression of CD20 in Human

  2005cites this paper
• Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children.

  2005cites this paper
• Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

  2005cites this paper
• Mammalian target of rapamycin (mTOR) inhibition in chronic lymphocytic B-cell leukemia: A new therapeutic option

  2005cites this paper
• Enhanced Expression of CD20 in Human Tumor B Cells Is Controlled through ERK-Dependent Mechanisms

  2005cites this paper
• Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemia

  2005cites this paper
• Genistein Induces G2 Arrest in Malignant B Cells by Decreasing IL-10 Secretion

  2004cites this paper
• Monoclonal antibody therapy in lymphoid leukemias.

  2004cites this paper
• Monoclonal Antibody Therapy in Chronic Lymphocytic Leukemia

  2004cites this paper
• Chronic Lymphocytic Leukemia

  2004cites this paper
• Pathogenesis of Impaired Cellular Immune Function in CLL

  2004cites this paper
• Cytokines and Soluble Molecules in CLL

  2004cites this paper
• Detection of Functional Platelet-Activating Factor Receptors on Leukemic B Cells of Chronic Lymphocytic Leukemic Patients

  2004cites this paper
• Chronic lymphocytic leukemia.

  2004cites this paper
• The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype.

  2003cites this paper
• Abnormal T-cell Function in B-cell Chronic Lymphocytic Leukaemia

  2003cites this paper
• IL-4 Biology: Impact on Normal and Leukemic CLL B Cells

  2003cites this paper
• IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells

  2003cites this paper
• The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia

  2003cites this paper
• B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules

  2002cites this paper
• Spontaneous apoptosis in chronic lymphocytic leukemia and its relationship to clinical and cell kinetic parameters.

  2001cites this paper
• Immunologie de la polypose nasosinusienne

  2001cites this paper